SYMBICORT® in the Treatment of COPD
Completed
- Conditions
- COPD
- Registration Number
- NCT00564499
- Lead Sponsor
- AstraZeneca
- Brief Summary
A Scientific Research Program to evaluate the efficacy of SYMBICORT® 320/9μg in the treatment of COPD in real life environment by General Practitioners
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- patients (m/f) with COPD (GOLD stadium III and IV)
Read More
Exclusion Criteria
- patients who recently quit smoking (<3months)
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method